Many Rezulin lawsuits have been filed due to countless deaths and life-threatening conditions that have occurred from use of the diabetes drug. Rezulin's removal is due to patients now having safer alternatives in its class of diabetes drugs.
Usually Rezulin lawsuits are aimed at Warner-Lambert, one of the drug manufacturers (the other being Parke-Davis), for negligence.
Additionally there has been evidence proving that Rezulin manufacturers were aware of the dangers well before its recall. This violation of patient's rights has been the primary cause for Rezulin lawsuits.
Rezulin lawsuit litigation:
There have been thousands of Rezulin lawsuits.
Aside from individual cases, there have been many class action lawsuits filled in an attempt to get Rezulin manufacturers to pay for the costs of strict monitoring of patients taking Rezulin to detect any liver or cardiac damage that could result.
Despite the time having passed from Rezulin's recall, people are still saying that are suffering from Rezulin's adverse affects.
As of March 21, 2000, the FDA asked the manufacturer of Rezulin (troglitazone) to remove the product from the market.
The "FDA took this action after its review of recent safety data on Rezulin and two similar drugs, rosiglitazone (Avandia) and pioglitazone (Actos), showed that Rezulin is more toxic to the liver than the other two drugs. Data to date show that Avandia and Actos, both approved in the past year, offer the same benefits as Rezulin without the same risk (FDA)."
Since 1997, liver toxicity has been a known side effect of Rezulin. The manufacter Parke-Davis, in compliance with the FDA, improved their label a number of times and recommended careful monitoring of liver function in people taking Rezulin.
After monitoring Avandia and Actos for up to nine months, it became clear that these newer drugs presented less risk of severe liver toxicity than Rezulin.
US Food and Drug Administration. "Rezulin to be Withdrawn from the Market." HHS News. Online. 22 March 2000.